These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 23824265)

  • 21. Lifestyle and risk factor management in people at high cardiovascular risk from Bulgaria, Croatia, Poland, Romania and the United Kingdom who participated in both the EUROASPIRE III and IV primary care surveys.
    De Backer G; De Bacquer D; Rydén L; Kotseva K; Gaita D; Georgiev B; Gotcheva N; Mancas S; Miličić D; Pająk A; Reiner Ž; Wood D;
    Eur J Prev Cardiol; 2016 Oct; 23(15):1618-27. PubMed ID: 27084894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High prevalence of dyslipidaemia subtypes and their associated personal and clinical attributes in Malaysian adults: the REDISCOVER study.
    Mohamed-Yassin MS; Baharudin N; Daher AM; Abu Bakar N; Ramli AS; Abdul-Razak S; Mohamed Noor Khan NA; Mohamad M; Yusoff K
    BMC Cardiovasc Disord; 2021 Mar; 21(1):149. PubMed ID: 33757445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment potential for dyslipidaemia management in patients with coronary heart disease across Europe: findings from the EUROASPIRE III survey.
    Reiner Ž; De Bacquer D; Kotseva K; Prugger C; De Backer G; Wood D;
    Atherosclerosis; 2013 Dec; 231(2):300-7. PubMed ID: 24267243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glycaemic control, dyslipidaemia and metabolic syndrome among recently diagnosed diabetes mellitus patients in Tamale Teaching Hospital, Ghana.
    Titty FK
    West Afr J Med; 2010; 29(1):8-11. PubMed ID: 20496331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence, management and control of diabetes mellitus and associated risk factors in primary health care in Portugal.
    Cortez-Dias N; Martins S; Belo A; Fiuza M;
    Rev Port Cardiol; 2010 Apr; 29(4):509-37. PubMed ID: 20734573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Diabetes control in type 2 diabetic subjects treated in primary health care].
    Fabian W; Majkowska L; Moleda P; Stefański A
    Pol Arch Med Wewn; 2006 Aug; 116(2):760-5. PubMed ID: 17424921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High prevalence of dyslipidaemia among persons with diabetes mellitus and hypertension at a tertiary hospital in Blantyre, Malawi.
    Katundu KGH; Mukhula V; Phiri T; Phiri C; Filisa-Kaphamtengo F; Chipewa P; Chirambo G; Mipando M; Mwandumba HC; Muula AS; Kumwenda J
    BMC Cardiovasc Disord; 2022 Dec; 22(1):557. PubMed ID: 36544081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sex Differences in the Prevalence of, and Trends in, Cardiovascular Risk Factors, Treatment, and Control in the United States, 2001 to 2016.
    Peters SAE; Muntner P; Woodward M
    Circulation; 2019 Feb; 139(8):1025-1035. PubMed ID: 30779652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Challenge of cardiovascular prevention in primary care: achievement of lifestyle, blood pressure, lipids and diabetes targets for primary prevention in England - results from ASPIRE-3-PREVENT cross-sectional survey.
    Kotseva K; Jennings C; Bassett P; Adamska A; Hobbs R; Wood D;
    Open Heart; 2024 Oct; 11(2):. PubMed ID: 39414309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lifestyle and risk factor management in people at high risk of cardiovascular disease. A report from the European Society of Cardiology European Action on Secondary and Primary Prevention by Intervention to Reduce Events (EUROASPIRE) IV cross-sectional survey in 14 European regions.
    Kotseva K; De Bacquer D; De Backer G; Rydén L; Jennings C; Gyberg V; Abreu A; Aguiar C; Conde AC; Davletov K; Dilic M; Dolzhenko M; Gaita D; Georgiev B; Gotcheva N; Lalic N; Laucevicius A; Lovic D; Mancas S; Miličić D; Oganov R; Pajak A; Pogosova N; Reiner Ž; Vulic D; Wood D; On Behalf Of The Euroaspire Investigators
    Eur J Prev Cardiol; 2016 Dec; 23(18):2007-2018. PubMed ID: 27638542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of high plasma triglyceride combined with low HDL-C levels and its association with smoking, hypertension, obesity, diabetes, sedentariness and LDL-C levels in the Canadian population. Canadian Heart Health Surveys Research Group.
    Connelly PW; Petrasovits A; Stachenko S; MacLean DR; Little JA; Chockalingam A
    Can J Cardiol; 1999 Apr; 15(4):428-33. PubMed ID: 10322252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Achievement of multiple therapeutic targets for cardiovascular disease prevention: Retrospective analysis of real practice in Italy.
    Figliuzzi I; Presta V; Citoni B; Miceli F; Simonelli F; Battistoni A; Coluccia R; Ferrucci A; Volpe M; Tocci G
    Clin Cardiol; 2018 Jun; 41(6):788-796. PubMed ID: 29604091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of diabetes and hypertension management by rural primary health-care workers (Behvarz workers) in Iran: a nationally representative observational study.
    Farzadfar F; Murray CJ; Gakidou E; Bossert T; Namdaritabar H; Alikhani S; Moradi G; Delavari A; Jamshidi H; Ezzati M
    Lancet; 2012 Jan; 379(9810):47-54. PubMed ID: 22169105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Persistent lipid abnormalities in statin-treated patients: Portuguese diabetic subpopulation of the Dyslipidaemia International Study (DYSIS).
    Marques da Silva P; Massano Cardoso S; Ferreira AM;
    Prim Care Diabetes; 2015 Aug; 9(4):283-9. PubMed ID: 25449144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suboptimal management of cardiovascular risk factors in coronary heart disease patients in primary care occurs particularly in women.
    Driscoll A; Beauchamp A; Lyubomirsky G; Demos L; McNeil J; Tonkin A
    Intern Med J; 2011 Oct; 41(10):730-6. PubMed ID: 21627740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group. European Action on Secondary Prevention by Intervention to Reduce Events.
    EUROASPIRE I and II Group; European Action on Secondary Prevention by Intervention to Reduce Events
    Lancet; 2001 Mar; 357(9261):995-1001. PubMed ID: 11293642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between obesity and therapeutic goal attainment in patients with concomitant hypertension and dyslipidemia.
    Chopra I; Kamal KM; Candrilli SD; Kanyongo G
    Postgrad Med; 2014 Jan; 126(1):66-77. PubMed ID: 24393753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycaemic status and prevalence of comorbid conditions among people with diabetes in Kerala.
    Menon VU; Guruprasad U; Sundaram KR; Jayakumar RV; Nair V; Kumar H
    Natl Med J India; 2008; 21(3):112-5. PubMed ID: 19004140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Awareness, treatment, and control of major cardiovascular risk factors in a small-scale Italian community: results of a screening campaign.
    Omboni S; Carabelli G; Ghirardi E; Carugo S
    Vasc Health Risk Manag; 2013; 9():177-85. PubMed ID: 23662063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dyslipidaemia in rural Australia: prevalence, awareness, and adherence to treatment guidelines in the Greater Green Triangle Risk Factor Study.
    Janus ED; Tideman PA; Dunbar JA; Kilkkinen A; Bunker SJ; Philpot B; Tirimacco R; Mc Namara K; Heistaro S; Laatikainen T
    Med J Aust; 2010 Feb; 192(3):127-32. PubMed ID: 20121678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.